Chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in chronic lung disease (oxygen use at 28 days in survivors) compared with no supplementation (moderate certainty).
2 findings from 1 review
Death or chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A probably leads to lower death or chronic lung disease (oxygen use at 28 days) compared with no supplementation (moderate certainty).
2 findings from 1 review
Death before 36 weeks' postmenstrual age · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in death before 36 weeks' postmenstrual age compared with no supplementation (moderate certainty).
1 finding from 1 review
Neurodevelopmental impairment at 18 to 22 months · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in neurodevelopmental impairment at 18 to 22 months compared with no supplementation (low certainty).
1 finding from 1 review
Intervention not reported
Withdrawals Participant withdrawal following randomization before or during receipt of the intervention because of consent or medical reason · adult survivors of critical illness
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) probably leads to higher vaginal delivery not achieved within 24 hours compared with low‐dose oral misoprostol (moderate certainty).
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) showed no clear difference in vaginal delivery not achieved in 24 hours compared with low‐dose vaginal misoprostol (low certainty).
1 finding from 1 review
Psychophysical testing for recovery of sense of smell · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection
It is very uncertain whether systemic corticosteroids plus intranasal… changes psychophysical testing for recovery of sense of smell compared with no intervention (very low certainty).
1 finding from 1 review
Recovery of sense of smell (as · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection
It is very uncertain whether palmitoylethanolamide and luteolin changes recovery of sense of smell (as compared with no intervention (very low certainty).
1 finding from 1 review
Recovery of kidney function · AKI patients receiving CKRT
Surface‐modified showed no clear difference in recovery of kidney function compared with standard double‐lumen catheter with identical geometry and flow design (low certainty).
1 finding from 1 review
Recovery of kidney function · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recovery of kidney function · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recovery of kidney function · CRRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Apgar score less than 7 at 5 minutes · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to lower apgar score at five minutes below seven compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · women with one previous lower segment caesarean section and requiring labour induction due to prolonged pregnancy or pre‐eclampsia,…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vaginal delivery not achieved within 24 hours · pregnant women with a previous low transverse caesarean section, singleton live pregnancy with cephalic presentation, period of gestation…
Foley catheter showed no clear difference in vaginal delivery not achieved within 24 hours compared with intravenous (IV) oxytocin (low certainty).
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vaginal delivery not achieved within 24 hours · pregnant women with 1 previous lower segment caesarean section at 37 weeks and beyond, with a BS of ≤ 6, intact membranes, reactive…
Vaginal isosorbide mononitrate may leads to higher vaginal delivery not achieved within 24 hours compared with foley catheter (low certainty).
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · pregnant women who previously had a lower segment CS and now have a singleton cephalic presentation after at least 36 completed weeks, not…
80 mL showed no clear difference in vaginal delivery not achieved within 24 hours compared with 30 mL Foley catheter (moderate certainty).
1 finding from 1 review
Intervention not reported
Global assessment of treatment success Satisfactory pace of recovery · people following primary uncemented THA
It is very uncertain whether the intervention changes global assessment of treatment success Satisfactory pace of recovery (very low certainty).
1 finding from 1 review